Takeda America Holdings has entered into an agreement to purchase URL Pharma for an upfront payment of $800m and future performance-based contingent earn out payments. With the completion of the acquisition, URL Pharma will be managed by ...
Tags: Takeda America Holdings, URL Pharma, acute and chronic gout